uniQure
uniQure Logo
About uniQure
uniQure NV is a biotechnology company specializing in gene therapy for severe genetic diseases. The company develops a modular platform to deliver single-treatment, potentially curative therapies. uniQure's clinical programs include HEMGENIX for hemophilia B and investigational gene therapies for Huntington's disease, mesial temporal lobe epilepsy, amyotrophic lateral sclerosis, and Fabry disease. The company also engages in licensing and development partnerships to advance its pipeline of innovative genomic medicines.
Address
Paasheuvelweg 25,
Amsterdam, 1105 BP
Netherlands
Year founded
2012
Number of employees
400-500
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
